Establishment Labs' fourth quarter revenue was $31.6 million, consistent with preannouncement. The company is focused on expense reduction, balance sheet security, and achieving positive adjusted EBITDA later this year and becoming cash flow positive in 2025.
Fourth quarter revenue of $31.6 million, consistent with preannouncement on January 9.
Fourth quarter net loss from operations of $22.1 million compared to a net loss of $13.2 million in the year-ago period.
Proforma cash balance of $90 million after $50 million private placement on January 9.
Launched Motiva Implants® in China.
The company provided 2024 revenue guidance of $174 million to $184 million, an increase of 5% to 11% over 2023. Guidance does not include revenue from Motiva Implants® in the United States, which is expected in 2024.
Analyze how earnings announcements historically affect stock price performance